spermidine has been researched along with Actinic Reticuloid Syndrome in 1 studies
Excerpt | Relevance | Reference |
---|---|---|
"More than one million new skin cancers are diagnosed yearly in the United States creating the need for effective primary and chemopreventive strategies to reduce the incidence, morbidity, and mortality associated with skin cancer." | 2.70 | Modulation of biologic endpoints by topical difluoromethylornithine (DFMO), in subjects at high-risk for nonmelanoma skin cancer. ( Alberts, DS; Bowden, GT; Einspahr, JG; Nelson, MA; Saboda, K; Warneke, J, 2002) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Einspahr, JG | 1 |
Nelson, MA | 1 |
Saboda, K | 1 |
Warneke, J | 1 |
Bowden, GT | 1 |
Alberts, DS | 1 |
1 trial available for spermidine and Actinic Reticuloid Syndrome
Article | Year |
---|---|
Modulation of biologic endpoints by topical difluoromethylornithine (DFMO), in subjects at high-risk for nonmelanoma skin cancer.
Topics: Aged; Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Biopsy; Cell Division; Eflornithine; Enzy | 2002 |